DIAGNOSIS

 Anti-CCP
≥ 5 mg/dl  N (%)		 RF > 1/80         N (%) CTx-II
> 0.3 ng/ml N (%)

Rheumatoid arthritis

16 (61.5)

21 (70)

11 (61)
Fibromyalgia

1(3.8)

--

--

Sjögren Sx

1(3.8)

1 (3.3)

--

Spondiloarthritis

1 (3.8)

2 (6.7)

3 (16.7)
Sclerodermia (Nº) (%)

1(3.8)

1 (3.3)

--
Transient undifferenciated polyarthritis

2( 7.7)

2 (6.7)

1 (5.6)
Lost at follow-up

4 (15.4)

3 (10)

3 (16.7)
Total

26 (100)

30 (100)

18 (100)
Table 3: Frequency and percentage distribution according to Anti-CCP values, RF, CTx-II positive and type of diagnosis at 12 monthfollow-up.